Last reviewed · How we verify
NCT05919875: iMBCT
Online Mindfulness-Based Cognitive Therapy in Depressed Sample
NA trial testing Unguided Mindfulness-Based Cognitive Therapy in Moderate Depressive Episode in 170 participants. Completed in 29 October 2024.
31 July 2024
Quick facts
| Lead sponsor | University of Warsaw |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 170 |
| Start date | 18 March 2024 |
| Primary completion | 31 July 2024 |
| Estimated completion | 29 October 2024 |
| Sites | 1 location across Poland |
Drugs / interventions tested
- Unguided Mindfulness-Based Cognitive Therapy
- Guided Mindfulness-Based Cognitive Therapy
Conditions studied
- Moderate Depressive Episode — all drugs for Moderate Depressive Episode →
- Mild Depressive Episode — all drugs for Mild Depressive Episode →
Sponsor
University of Warsaw
Who can join
18 and older, any sex, with Moderate Depressive Episode or Mild Depressive Episode. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this clinical trial is to evaluate the effectiveness of the online 6-weeks Mindfulness-Based Cognitive Therapy (iMBCT) in depressed sample and compare the guided intervention to an unguided one. The main questions the study aims to answer are: * To what extent completing iMBCT will reduce the severity of depressive symptoms in mild to moderately depressed sample? * What are the differences in participants who completed the program or responded to treatment and those who discontinued it? * What are the differences in treatment effect between two active conditions (guided and unguided iMBCT) and a passive one - waiting-list group? Researchers will compare two iMBCT interventions with a waiting-list group to assess the therapeutic effects of iMBCT on depression, anxiety and other measures related to the mental health.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05919875
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other University of Warsaw trials
Trials by the same sponsor.
- NCT07183826 — Internet-Based Mindfulness-Based Cognitive Therapy (iMBCT) for Chronic Tinnitus Patients · NA · recruiting
- NCT07128017 — Online MBCT for Adjustment Disorder During COVID-19: Efficacy, Mechanisms, and RCT · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05919875 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Warsaw
- Last refreshed: 25 November 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05919875.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing